April 28, 2018

William Werkmeister – Partner of the International Cancer Impact Fund

After graduating from Cornell, William Werkmeister started his career as an investment banker at Salomon Smith Barney and Citigroup and then worked for a series of state-sponsored venture capital funds that supported translational research and building technologies out of various academic labs in Texas and New York.  He then launched […]
April 17, 2018

Phillip Polakoff MD on the Biggest Challenges in Health and the delivery of healthcare in the U.S.A and worldwide

Phil Polakoff who for 35 years has been engaged in the healthcare field and offers a unique perspective on where we are and where we are going. Phil, what do you see as the biggest challenges in health and the delivery of healthcare in the U.S.A and worldwide? Phil Polakoff: […]
November 13, 2017

Anthony Gringeri, PhD, CEO of ImmunoCellular Therapeutics, on their Immune-Based Therapies for the Treatment of Cancer

We interviewed Dr. Anthony Gringeri, President and CEO of Immunocellular Therapeutics, a company developing immune-based therapies for the treatment of cancer. ImmunoCellular is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells. Joining Dr. Gringeri is Dr. Steven Swanson, Senior Vice President […]
August 24, 2017

George Szewczyk, PhD, CEO of BioKier on Medical Food to Treat Diabetes and Improve Metabolic Health

We interviewed George Szewczyk, President and CEO of BioKierx, a company developing a technology that encapsulates nutrients, and delivering them to the colon. Mr. Szewczyk is an accomplished leader in the field of diabetes with years of experience. BioKier has developed a very innovative approach to diabetes by way of medical food […]
August 24, 2017

Dr. Dara Huang on the Power of Cannabidiol Oil

We interviewed Dr. Dara Huang, a Manhattan-based Nephrologist and Brown alumni working in the medical marijuana space, specifically CBD-related products as an effective means to treat pain-related conditions. Dr. Huang has developed a medical practice dedicated to helping patients develop treatment plans for their chronic pain. Her years of experience have […]
July 31, 2017

Jerry Mezger, CEO of Harbor MedTech on Advancements in Wound Care & Surgical Mesh

Brett Johnson: This is Brett Johnson with OneMedRadio and I am here with Jerry Mezger, CEO of Harbor MedTech, a medical device company working in the wound care and surgical mesh space, that has developed some exciting new products that we hope to speak with him about today. Welcome, Jerry. […]
July 31, 2017

Chris Schaber, CEO of Soligenix on Treating Oral Mucositis in Head and Neck Cancer Patients

Brett Johnson: Good morning, today we are with Dr. Christopher Schaber, President and CEO of Soligenix, a company developing drug therapies in rare diseases and areas of unmet medical need, including a treatment for oral mucositis in head and neck cancer patients. Chris, your drug, Dusquetide or SGX942, sounds like […]
June 6, 2017

Andre DiMino: CEO of ADM Tronics on Rollout of Hearing Protection Products

Brett Johnson: We are with André DiMino, CEO talking about ADM Tronics and some interesting developments at the company. Andre can you tell us about ADM Tronics? André DiMino: What makes the company special is that it has developed a significant internal capability to bring a high technology, medical device product […]
May 9, 2017

Gene Williams – Executive Chairman of ProMis

Brett Johnson: Can you tell us about ProMIS? Gene Williams: ProMIS is a biotech company that’s focusing on creating best in class disease modifying therapy for Alzheimer’s and other forms of dementia. There are a lot of symptomatic therapies out there now that help reduce the cognitive decline symptoms of […]
April 11, 2017

David Buzkin on Microcaps and the IPOs

David Bukzin is the national partner -in charge of Marcum’s SEC practice with a focus on securities underwritings for emerging growth companies he organized the Marcum Microcap conference in 2010 to facilitate development for  smaller size public companies under $500 market caps. He discusses the origins and mission of the […]
April 11, 2017

Glynn Wilson – CEO of TapImmune on Vaccines for Cancer

Immunotherapy is the future of cancer treatment and TapImmune has been leading the charge. CEO Glynn Wilson discusses the advances made in the ovarian and breast cancer. The company is taking a vaccine approach to reduce recurrence of cancer and to improve progression free survival and in some cases to […]
March 28, 2017

James Manuso- CEO of RespireRX

Brett Johnson: Today I am with Dr. James Manuso. He is the President & CEO of RespireRX Pharmaceuticals. The stock symbol is RSPI. It’s an innovative company that has been developing drugs for respiratory diseases for which there are no medicines at this time. Thanks for joining us today, Jim. […]
March 28, 2017

David Baker – Chief Commercial Officer of Alcobra

Brett Johnson:  We are here with David Baker from Alcobra Pharmaceuticals talking about the company and this development of their ADHD drug. Thanks for joining us today. Can you tell us, what does Alcobra do? David Baker: Alcobra is a CNS specialty pharma company. We only have focused on CNS […]
March 11, 2017

Richard Daly – CEO of Neuralstem

 Rich Daly has  been in the pharmaceutical industry for twenty-five + years having held senior positions at Abbott, Takeda, AstraZeneca and Bristol-Myers Squibb. At Takeda, he was the 14th employee in their US start-up and  helped it grow to 5,000 employees in the U.S. and about $6B in sales. HIs […]
March 11, 2017

Dr. Christopher Schaber – President and CEO of Soligenix

Dr. Christopher Schaber is the President and CEO of Soligenix, a late stage biopharmaceutical company with a pipeline of pharmaceutical products to treat a variety of rare diseases with an unmet need. Brett Johnson speaks with Dr. Schaber to discuss Soligenix’s mature pipeline of products, their business in biodefense, and […]
February 19, 2017

Tom Malcolm – CEO and Co-Founder of Excision BioTherapeutics

Thomas Malcolm Ph.D is the CEO, President and Co-Founder of Excision BioTherapeutics, a company working in the area of gene editing and CRISPR technology, with a primary focus on HIV. Brett Johnson speaks with Dr. Malcolm to discuss the Company’s mission to use gene therapy to cure HIV, why the CRISPR space has exploded […]
February 14, 2017

Doug Daniels – CEO of Stroma

Doug Daniels – CEO of Stroma Stroma Medical has developed an innovative approach to eye color. Its technology changes eye color from dark to light with a 30-second procedure. The company has received over two million requests regarding this treatment and is now conducting clinical trials and building an international distribution network as it prepares […]
January 28, 2017

David Otto – MartinDavis PLLC and Otto Capital on Cannabinoids

David Otto is the Managing Partner and Founder of MartinDavis Law PLLC and Otto Capital. He has recently been focused in the medical marijuana space, pushing for more appropriate regulatory schemes and helping to communicate the broader applications that cannabinoids may hold for the treatment of various medical conditions. He spoke with Brett Johnson about his involvement […]
January 28, 2017

Paul Harte – Portfolio Manager at Mt. Lucas Management

Paul Harte, Portfolio Manager at the Mount Lucas Management Fund, talks to Brett Johnson about the microcap space, and how he discovered two companies that he perceives as grossly undervalued: Neurotrope and Promises Neurosciences. Read below for the full transcript, or click below to listen to the audio interview. Brett […]
January 5, 2017

Yong H Rho – CEO of Obetat

Brett Johnson – Can you first tell us, what does Obetat do? What is your vision for obesity treatment? Yong H. Rho – OBETAT, a pre-clinical stage company developing an innovative new class of potent and safe anti-obesity peptide based drug meeting unmet needs of treating severe obesity, Prader-Will syndrome(Orphan […]